GB9819685D0
(en)
*
|
1998-09-10 |
1998-11-04 |
Norton Healthcare Ltd |
Anti-inflammatory pharmaceutical formulations
|
US6514525B2
(en)
|
1998-09-10 |
2003-02-04 |
Norton Healthcare Ltd |
Anti-inflammatory pharmaceutical formulations
|
US8231899B2
(en)
*
|
1998-09-10 |
2012-07-31 |
Nycomed Danmark Aps |
Quick release pharmaceutical compositions of drug substances
|
US6387410B1
(en)
|
1998-09-10 |
2002-05-14 |
Norton Healthcare Ltd |
Anti-inflammatory pharmaceutical formulations
|
US20080113025A1
(en)
*
|
1998-11-02 |
2008-05-15 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
|
RU2236847C2
(ru)
*
|
1998-11-02 |
2004-09-27 |
Илан Корпорейшн, Плк. |
Композиции в виде множества частиц с модифицированным высвобождением
|
US20060240105A1
(en)
*
|
1998-11-02 |
2006-10-26 |
Elan Corporation, Plc |
Multiparticulate modified release composition
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
US20090297597A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Gary Liversidge |
Modified Release Ticlopidine Compositions
|
WO2008079102A1
(en)
*
|
2005-05-10 |
2008-07-03 |
Elan Corporation, Plc |
Modified release loxoprofen compositions
|
US6183779B1
(en)
|
1999-03-22 |
2001-02-06 |
Pharmascience Inc. |
Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
|
IE990406A1
(en)
*
|
1999-05-20 |
2000-12-27 |
Elan Corp Plc |
Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
|
RS50303B
(sr)
*
|
1999-09-28 |
2009-09-08 |
Panacea Biotec Limited, |
Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
|
GB9923436D0
(en)
*
|
1999-10-04 |
1999-12-08 |
American Home Prod |
Pharmaceutical compositions
|
IL149352A0
(en)
|
1999-10-29 |
2002-11-10 |
Euro Celtique Sa |
Controlled release hydrocodone formulations
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
CN1230167C
(zh)
*
|
1999-12-22 |
2005-12-07 |
法马西亚公司 |
环加氧酶-2抑制剂的二元释放组合物
|
SE0000774D0
(sv)
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
EP1268430A1
(de)
*
|
2000-03-21 |
2003-01-02 |
Astion Development APS |
Chemischer komplex bestehen aus pyridine-carboxy-substituierte und histamin-h2 rezeptor antagonisten
|
US20020035107A1
(en)
*
|
2000-06-20 |
2002-03-21 |
Stefan Henke |
Highly concentrated stable meloxicam solutions
|
EP1252886A1
(de)
*
|
2001-04-27 |
2002-10-30 |
Universiteit Gent |
Pharmazeutische Pelletformulierungen für eine kontrollierte Freisetzung
|
AU2002212200A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Universiteit Gent |
Controlled release pharmaceutical pellet compositions for reducing side effects of drugs
|
JP2004512354A
(ja)
|
2000-10-30 |
2004-04-22 |
ユーロ−セルティーク,エス.エイ. |
ヒドロコドン放出制御製剤
|
DE10108122A1
(de)
*
|
2001-02-21 |
2002-10-02 |
Gruenenthal Gmbh |
Arzneimittel auf Basis von Tramadol
|
NZ528607A
(en)
*
|
2001-03-15 |
2007-11-30 |
Enteron Pharmaceuticals Inc |
Method of treating inflammatory GI disorders using topically active corticosteroids to reduce symptoms without causing the side effects associated with systemic steroid administration
|
MXPA03010705A
(es)
*
|
2001-05-25 |
2004-05-27 |
Cephalon Inc |
Formulaciones farmaceuticas solidas que comprenden modafinil.
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
US6926907B2
(en)
|
2001-06-01 |
2005-08-09 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
SE0102993D0
(sv)
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
DE10161077A1
(de)
*
|
2001-12-12 |
2003-06-18 |
Boehringer Ingelheim Vetmed |
Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
|
US20030161875A1
(en)
*
|
2002-02-27 |
2003-08-28 |
Deepak Murpani |
Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
|
GB0205253D0
(en)
|
2002-03-06 |
2002-04-17 |
Univ Gent |
Immediate release pharmaceutical granule compositions and a continuous process for making them
|
US6696496B2
(en)
*
|
2002-03-28 |
2004-02-24 |
Synthon Bv |
Low water-soluble venlafaxine salts
|
US7229644B2
(en)
*
|
2002-05-23 |
2007-06-12 |
Cephalon, Inc. |
Pharmaceutical formulations of modafinil
|
CN1674877A
(zh)
*
|
2002-06-07 |
2005-09-28 |
兰贝克赛实验室有限公司 |
控释的多单位药物释放系统
|
SI21301A
(sl)
*
|
2002-09-11 |
2004-04-30 |
LEK farmacevtska družba d.d. |
Farmacevtska oblika z nadzorovanim sproščanjem
|
US20040116532A1
(en)
|
2002-09-13 |
2004-06-17 |
Craig Heacock |
Pharmaceutical formulations of modafinil
|
WO2004026256A2
(en)
*
|
2002-09-20 |
2004-04-01 |
Alpharma, Inc. |
Sustained-release opioid formulations and methods of use
|
US20040220153A1
(en)
*
|
2002-09-24 |
2004-11-04 |
Jost-Price Edward Roydon |
Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
|
US8992980B2
(en)
|
2002-10-25 |
2015-03-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Water-soluble meloxicam granules
|
US20040186180A1
(en)
|
2003-03-21 |
2004-09-23 |
Gelotte Cathy K. |
Non-steroidal anti-inflammatory drug dosing regimen
|
CN102166184A
(zh)
*
|
2003-03-21 |
2011-08-31 |
麦克内尔-Ppc股份有限公司 |
非甾体抗炎药物的给药方案
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
US8802139B2
(en)
*
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
US8273371B2
(en)
|
2003-06-27 |
2012-09-25 |
Johan Adriaan Martens |
Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
|
GB0315012D0
(en)
|
2003-06-27 |
2003-07-30 |
Leuven K U Res & Dev |
Zeotiles
|
JP2009513512A
(ja)
*
|
2003-07-09 |
2009-04-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
メロキシカムを含む組成物
|
CA2524300C
(en)
*
|
2003-08-08 |
2008-10-28 |
Biovail Laboratories International Srl |
Modified-release tablet of bupropion hydrochloride
|
TWI372066B
(en)
*
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
US20050095299A1
(en)
*
|
2003-10-30 |
2005-05-05 |
Wynn David W. |
Controlled release analgesic suspensions
|
NZ546337A
(en)
*
|
2003-10-31 |
2009-03-31 |
Takeda Pharmaceutical |
Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80
|
BRPI0415557A
(pt)
*
|
2003-10-31 |
2006-12-26 |
Hexal Ag |
formulação contendo ingrediente ativo farmacêutico com revestimento
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
SI21638A
(sl)
*
|
2003-11-12 |
2005-06-30 |
LEK farmacevtska družba d.d. |
Farmacevtska oblika z nadzorovanim sproščanjem ketoprofena
|
US7387793B2
(en)
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
SI21637A
(sl)
*
|
2003-12-23 |
2005-06-30 |
LEK farmacevtska dru�ba d.d. |
Farmacevtska oblika z nadzorovanim sproščanjem
|
EP1568369A1
(de)
*
|
2004-02-23 |
2005-08-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
|
DE102004021281A1
(de)
*
|
2004-04-29 |
2005-11-24 |
Boehringer Ingelheim Vetmedica Gmbh |
Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
|
DE102004030409A1
(de)
*
|
2004-06-23 |
2006-01-26 |
Boehringer Ingelheim Vetmedica Gmbh |
Neue Verwendung von Meloxicam in der Veterinärmedizin
|
TWI376242B
(en)
*
|
2004-06-29 |
2012-11-11 |
Nycomed Danmark Aps |
Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
WO2006078320A2
(en)
|
2004-08-04 |
2006-07-27 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
JP2008524332A
(ja)
*
|
2004-12-20 |
2008-07-10 |
コレジウム ファーマシューティカル, インク. |
睡眠傷害のための医薬組成物
|
GB0501809D0
(en)
*
|
2005-01-28 |
2005-03-09 |
Pharmakodex Ltd |
Anti-migraine formulations
|
JP2009514989A
(ja)
*
|
2005-05-10 |
2009-04-09 |
エラン コーポレーション ピーエルシー |
改変放出ロキソプロフェン組成物
|
EP1888045B1
(de)
*
|
2005-05-24 |
2010-09-08 |
Flamel Technologies |
Orale pharmazeutische zusammensetzung zur behandlung einer cox-2-vermittelten erkrankung
|
BRPI0613547A2
(pt)
*
|
2005-07-20 |
2011-01-18 |
Panacea Biotec Ltd |
forma de dosagem de liberação modificada e respectivo uso
|
CN100346778C
(zh)
*
|
2005-07-22 |
2007-11-07 |
海南康力元药业有限公司 |
尼美舒利缓释组合物
|
BRPI0617208A2
(pt)
*
|
2005-09-30 |
2011-07-19 |
Boehringer Ingelheim Vetmed |
preparação farmacêutica contendo meloxicam
|
KR100831771B1
(ko)
*
|
2005-10-27 |
2008-05-27 |
주식회사종근당 |
서방출과 pH 의존성 속방출을 나타내는 약제학적 조성물
|
US20070141151A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Silver David I |
Lansoprazole orally disintegrating tablets
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
EP1965774A2
(de)
*
|
2005-12-30 |
2008-09-10 |
Cogentus Pharmaceuticals, Inc. |
Orale pharmazeutische formulierungen mit nichtsteroidalen entzündungshemmern und säurehemmern
|
US20070184115A1
(en)
*
|
2005-12-30 |
2007-08-09 |
Biovail Laboratories International S.R.L. |
Modified release formulations of tramadol and uses thereof
|
US8202535B2
(en)
|
2006-01-06 |
2012-06-19 |
Acelrx Pharmaceuticals, Inc. |
Small-volume oral transmucosal dosage forms
|
US8252329B2
(en)
|
2007-01-05 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US8865743B2
(en)
|
2006-01-06 |
2014-10-21 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8535714B2
(en)
*
|
2006-01-06 |
2013-09-17 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
WO2007099433A2
(en)
*
|
2006-02-28 |
2007-09-07 |
Wockhardt Ltd |
Delayed release dosage form of pantoprazole or salt thereof
|
WO2007103113A2
(en)
*
|
2006-03-06 |
2007-09-13 |
Pozen Inc. |
Dosage forms for administering combinations of drugs
|
US9265732B2
(en)
|
2006-03-06 |
2016-02-23 |
Pozen Inc. |
Dosage forms for administering combinations of drugs
|
CN104825397A
(zh)
|
2006-04-03 |
2015-08-12 |
伊萨·奥迪迪 |
含有机溶胶涂层的受控释放递送物件
|
JP5844028B2
(ja)
|
2006-04-04 |
2016-01-13 |
ケージー アクキュイシチオン エルエルシー |
抗血小板薬及び酸阻害薬を含む経口剤形
|
AU2007242405A1
(en)
*
|
2006-04-24 |
2007-11-01 |
Panacea Biotec Ltd. |
Novel low dose pharmaceutical compositions comprising nimesulide, preparation and use thereof
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
EP2019679B1
(de)
|
2006-05-23 |
2018-06-20 |
Theracos, Inc. |
Glucosetransporthemmer und anwendungsverfahren
|
US20070281927A1
(en)
*
|
2006-06-06 |
2007-12-06 |
Shanthakumar Tyavanagimatt |
Anti-inflammatory and analgesic compositions and related methods
|
BRPI0602179A
(pt)
*
|
2006-06-08 |
2008-01-22 |
Biolab Sanus Farmaceutica Ltda |
composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação
|
US7893053B2
(en)
|
2006-06-16 |
2011-02-22 |
Theracos, Inc. |
Treating psychological conditions using muscarinic receptor M1 antagonists
|
US8748419B2
(en)
|
2006-06-16 |
2014-06-10 |
Theracos, Inc. |
Treating obesity with muscarinic receptor M1 antagonists
|
KR100812538B1
(ko)
*
|
2006-10-23 |
2008-03-11 |
한올제약주식회사 |
약물 제어방출형 메트포르민-글리메피리드 복합제제
|
RU2009123445A
(ru)
*
|
2006-11-21 |
2010-12-27 |
МакНЕЙЛ-ППС, ИНК. (US) |
Анальгетические суспензии модифицированного высвобождения
|
DK2064222T3
(da)
|
2007-04-02 |
2014-07-21 |
Theracos Inc |
Benzyliske glycosid-derivater og fremgangsmåder til anvendelse deraf
|
US20090012165A1
(en)
*
|
2007-07-03 |
2009-01-08 |
Sucampo Ag |
Pharmaceutical combination of nsaid and prostaglandin compound
|
EP2604257B1
(de)
*
|
2007-08-07 |
2017-06-28 |
Acelrx Pharmaceuticals, Inc. |
Orale transmukosale Dosierungsformen mit Sufentanil und Triazolam
|
WO2009026537A1
(en)
|
2007-08-23 |
2009-02-26 |
Theracos, Inc. |
Benzylbenzene derivatives and methods of use
|
WO2009055925A1
(en)
*
|
2007-10-31 |
2009-05-07 |
Equitech Corporation |
Enhanced nsaid formulations
|
WO2009085952A1
(en)
|
2007-12-20 |
2009-07-09 |
Brookwood Pharmaceuticals, Inc. |
Process for preparing microparticles having a low residual solvent volume
|
US8372432B2
(en)
*
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
CA2720108C
(en)
*
|
2008-03-11 |
2016-06-07 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
WO2009118764A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Panacea Biotec Limited |
Pharmaceutical composition comprising diclofenac and paracetamol
|
BRPI0916769A2
(pt)
|
2008-07-15 |
2017-09-26 |
Theracos Inc |
derivados de benzilbenzeno deuterados e métodos de uso
|
ES2599330T3
(es)
|
2008-08-22 |
2017-02-01 |
Theracos Sub, Llc |
Proceso para la preparación de inhibidores de SGLT2
|
US9220698B2
(en)
|
2008-09-09 |
2015-12-29 |
Pozen Inc. |
Method for delivering a pharmaceutical composition to patient in need thereof
|
US8945592B2
(en)
*
|
2008-11-21 |
2015-02-03 |
Acelrx Pharmaceuticals, Inc. |
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
|
EP2379561B1
(de)
|
2008-11-25 |
2015-11-04 |
University Of Rochester |
Mlk-inhibitoren und anwendungsverfahren
|
WO2010099508A1
(en)
|
2009-02-26 |
2010-09-02 |
Theraquest Biosciences, Inc. |
Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
|
EA201290026A1
(ru)
|
2009-06-25 |
2012-07-30 |
Астразенека Аб |
Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
|
EP2445344A4
(de)
*
|
2009-06-25 |
2013-01-23 |
Pozen Inc |
Verfahren zur behandlung eines patienten mit bedarf an einer aspirintherapie
|
EP2477612A2
(de)
*
|
2009-09-17 |
2012-07-25 |
Evonik Degussa Corporation |
Nach freisetzungsprofil unterschiedliche implantatvorrichtungen sowie verfahren zu ihrer herstellung und verwendung
|
CN102647971B
(zh)
|
2009-10-12 |
2016-03-16 |
贝林格尔.英格海姆维特梅迪卡有限公司 |
用于包含美洛昔康的组合物的容器
|
US20110091544A1
(en)
*
|
2009-10-16 |
2011-04-21 |
Acelrx Pharmaceuticals, Inc. |
Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
|
US9198861B2
(en)
|
2009-12-22 |
2015-12-01 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
US8597681B2
(en)
|
2009-12-22 |
2013-12-03 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
TR200908308A1
(tr)
|
2010-01-18 |
2011-08-22 |
Turgut İlaçlari A.Ş. |
Etodolak içeren sürekli salım tablet formulasyonu
|
MX2012010077A
(es)
|
2010-03-03 |
2012-09-12 |
Boehringer Ingelheim Vetmed |
Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
|
GB201003731D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Immediate/delayed drug delivery
|
GB201003766D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Pulsatile drug release
|
GB201003734D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Delayed prolonged drug delivery
|
US9795568B2
(en)
|
2010-05-05 |
2017-10-24 |
Boehringer Ingelheim Vetmedica Gmbh |
Low concentration meloxicam tablets
|
CN103153994B
(zh)
|
2010-05-24 |
2016-02-10 |
罗切斯特大学 |
双环杂芳基激酶抑制剂及使用方法
|
EP2394641A1
(de)
|
2010-05-30 |
2011-12-14 |
Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi |
Pharmazeutische Formulationen von Lornoxicam
|
WO2011153712A1
(en)
|
2010-06-12 |
2011-12-15 |
Theracos, Inc. |
Crystalline form of benzylbenzene sglt2 inhibitor
|
ES2716865T3
(es)
|
2011-02-18 |
2019-06-17 |
Scripps Research Inst |
Diferenciación dirigida de células precursoras de oligodendrocitos a un destino celular mielinizante
|
KR101310099B1
(ko)
*
|
2011-04-13 |
2013-09-23 |
안국약품 주식회사 |
아세클로페낙 함유 방출제어형 정제
|
ES2755075T3
(es)
|
2011-05-05 |
2020-04-21 |
Hennig Arzneimittel Gmbh&Co Kg |
Forma farmacológica para la liberación dirigida de principios activos
|
DE102011075354A1
(de)
*
|
2011-05-05 |
2012-11-08 |
Hennig Arzneimittel Gmbh & Co. Kg |
Arzneiform zur gezielten Freigabe von Wirkstoffen
|
EA201391643A1
(ru)
*
|
2011-05-06 |
2014-07-30 |
ГЛЭКСОСМИТКЛАЙН ЭлЭлСи |
Составы с замедленным высвобождением парацетамола
|
US8741885B1
(en)
|
2011-05-17 |
2014-06-03 |
Mallinckrodt Llc |
Gastric retentive extended release pharmaceutical compositions
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
US9050335B1
(en)
|
2011-05-17 |
2015-06-09 |
Mallinckrodt Llc |
Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
|
US8524664B2
(en)
|
2011-06-02 |
2013-09-03 |
Colorado Seminary, Which owns and Operates The Univeristy of Denver |
Methods of treating overproduction of cortisol using ACTH antagonist peptides
|
ES2394888B1
(es)
*
|
2011-06-15 |
2013-09-23 |
Farmalider, S.A. |
Forma farmacéutica de liberación modificada de dexketoprofeno e inhibidor de la bomba de protones y uso de la misma.
|
UA115139C2
(uk)
|
2011-12-28 |
2017-09-25 |
Поузен Інк. |
Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
|
CN107569690A
(zh)
*
|
2012-01-04 |
2018-01-12 |
韦尔斯利医药有限公司 |
用于缓解尿频的延长释放制剂及其使用方法
|
CN102600108A
(zh)
*
|
2012-01-17 |
2012-07-25 |
广州科的信医药技术有限公司 |
一种氟比洛芬缓释胶囊及其制备方法
|
WO2014085795A1
(en)
|
2012-11-30 |
2014-06-05 |
University Of Rochester |
Mixed lineage kinase inhibitors for hiv/aids therapies
|
CN103877085B
(zh)
*
|
2013-10-16 |
2016-05-04 |
山西兰花药业有限公司 |
酮洛芬奥美拉唑缓释微丸及其制备方法
|
DK3087980T3
(en)
|
2013-12-23 |
2019-02-18 |
Xiaoguang Wen |
DOUBLE LAYER TABLE AND METHOD OF PRODUCING THEREOF
|
CN105777624A
(zh)
*
|
2014-12-26 |
2016-07-20 |
辽宁药联制药有限公司 |
一种微粉化吗尼氟酯及其组合物
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
WO2017100559A1
(en)
*
|
2015-12-10 |
2017-06-15 |
Cogwellin Llc |
Controlled release formulations of salicylate-releasing actives
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
WO2019199246A1
(en)
|
2018-04-13 |
2019-10-17 |
Santa Farma İlaç Sanayi̇ A.Ş. |
A sustained release formulation comprising acemetacin with bimodal in vitro release
|
CN109111469A
(zh)
*
|
2018-10-09 |
2019-01-01 |
中国药科大学 |
一种含氯诺昔康的共无定形复合物
|